Laparoscopic Ovarian Transposition and Ovariopexy for Fertility Preservation in Patients Treated with Pelvic Radiotherapy with or without Chemotherapy.
Ovarian transposition
cancer
fertility preservation
ovariopexy
pelvic radiation
Journal
Facts, views & vision in ObGyn
ISSN: 2032-0418
Titre abrégé: Facts Views Vis Obgyn
Pays: Belgium
ID NLM: 101578773
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
entrez:
22
2
2020
pubmed:
23
2
2020
medline:
23
2
2020
Statut:
ppublish
Résumé
Preservation of fertility in cancer patients of reproductive age is a concern for both the patient and the clinician. In this study, we aimed to study the effectiveness of laparoscopic ovarian transposition or ovariopexy in preserving ovarian function in women undergoing pelvic radiotherapy with or without chemotherapy for pelvic tumours. The records of patients who underwent laparoscopic ovarian transposition or ovariopexy prior to pelvic radiation therapy between 2002 and 2018 were reviewed retrospectively. Thirty-nine women or adolescent girls with a diagnosis of cervical cancer (n=15), Hodgkin's lymphoma (n=6) or other types of pelvic tumours (n=18) were included in the study. The majority of patients had bilateral (n=25) or unilateral (n=8) ovarian transposition prior to radiotherapy. Nine out of 10 (90%) patients with soft tissue tumors, Ewing sarcoma or ependymoma, five out of seven (71.4%) patients with Hodgkin's lymphoma, two patients (100%) with rectal and anal cancer, and six out of 15 (40%) with cervical cancer retained ovarian function. Patients with cervical cancer, those who received concomitant chemotherapy and those older than 30 years were more likely to experience ovarian failure. Five patients conceived spontaneously and two women had four live births. Laparoscopic repositioning of the ovaries out of the radiation field in order to protect ovarian function in patients receiving radiotherapy appears to be effective in the majority of patients. The procedure seems safe and should be considered either as a sole procedure or in association with other fertility preservation methods prior to pelvic radiotherapy.
Sections du résumé
BACKGROUND
BACKGROUND
Preservation of fertility in cancer patients of reproductive age is a concern for both the patient and the clinician. In this study, we aimed to study the effectiveness of laparoscopic ovarian transposition or ovariopexy in preserving ovarian function in women undergoing pelvic radiotherapy with or without chemotherapy for pelvic tumours.
METHODS
METHODS
The records of patients who underwent laparoscopic ovarian transposition or ovariopexy prior to pelvic radiation therapy between 2002 and 2018 were reviewed retrospectively.
RESULTS
RESULTS
Thirty-nine women or adolescent girls with a diagnosis of cervical cancer (n=15), Hodgkin's lymphoma (n=6) or other types of pelvic tumours (n=18) were included in the study. The majority of patients had bilateral (n=25) or unilateral (n=8) ovarian transposition prior to radiotherapy. Nine out of 10 (90%) patients with soft tissue tumors, Ewing sarcoma or ependymoma, five out of seven (71.4%) patients with Hodgkin's lymphoma, two patients (100%) with rectal and anal cancer, and six out of 15 (40%) with cervical cancer retained ovarian function. Patients with cervical cancer, those who received concomitant chemotherapy and those older than 30 years were more likely to experience ovarian failure. Five patients conceived spontaneously and two women had four live births.
CONCLUSION
CONCLUSIONS
Laparoscopic repositioning of the ovaries out of the radiation field in order to protect ovarian function in patients receiving radiotherapy appears to be effective in the majority of patients. The procedure seems safe and should be considered either as a sole procedure or in association with other fertility preservation methods prior to pelvic radiotherapy.
Types de publication
Journal Article
Langues
eng
Pagination
235-242Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2019 Facts, Views & Vision.
Références
J Hum Reprod Sci. 2015 Jan-Mar;8(1):3-13
pubmed: 25838742
Gynecol Oncol. 1990 Nov;39(2):155-9
pubmed: 2121629
Clin Med Insights Reprod Health. 2013 Mar 21;7:49-59
pubmed: 24453519
Fertil Steril. 1998 Aug;70(2):381-3
pubmed: 9696243
J Reprod Med. 2009 Apr;54(4):203-7
pubmed: 19438160
J Reprod Med. 2004 Jul;49(7):573-4
pubmed: 15305832
Expert Opin Pharmacother. 2015 May;16(7):1009-20
pubmed: 25826240
J Ovarian Res. 2014 Jun 25;7:69
pubmed: 24995040
Med Dosim. 2007 Fall;32(3):204-10
pubmed: 17707201
Gynecol Oncol. 1995 Jan;56(1):3-7
pubmed: 7821844
Am J Obstet Gynecol. 2003 Feb;188(2):367-70
pubmed: 12592241
Cancer. 1996 Jun 15;77(12):2638-45
pubmed: 8640716
Cancer. 1999 Nov 15;86(10):2138-42
pubmed: 10570443
Fertil Steril. 2000 Oct;74(4):743-8
pubmed: 11020517
Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):50-3
pubmed: 1733218
Fertil Steril. 2013 Nov;100(5):1214-23
pubmed: 24011612
Hum Reprod Update. 1998 May-Jun;4(3):248-59
pubmed: 9741709
Lancet Oncol. 2013 Dec;14(13):e601-8
pubmed: 24275133
J Obstet Gynaecol Res. 2011 Jul;37(7):825-9
pubmed: 21450024
Hum Reprod. 1998 Mar;13(3):660-3
pubmed: 9572430
Gynecol Oncol. 1993 May;49(2):206-14
pubmed: 8504989
Fertil Steril. 2012 Jun;97(6):1387-93.e1-2
pubmed: 22464082
Cancer. 1976 Feb;37(2 Suppl):1111-25
pubmed: 766956
J Minim Invasive Gynecol. 2017 Jan 1;24(1):28-35
pubmed: 27614150
Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):445-450
pubmed: 27653002
J Gastrointest Surg. 2009 Jun;13(6):1111-5
pubmed: 19224294
Strahlenther Onkol. 1991 May;167(5):273-6
pubmed: 2038709
Gynecol Oncol. 2007 Apr;105(1):234-7
pubmed: 17240431
Curr Oncol. 2013 Dec;20(6):e602-7
pubmed: 24311962
Fertil Steril. 2009 Mar;91(3):935.e15-6
pubmed: 18951125
Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3418-25
pubmed: 26439037
Curr Opin Obstet Gynecol. 2005 Feb;17(1):21-6
pubmed: 15711407
Fertil Steril. 2003 May;79(5):1204-6
pubmed: 12738518
J Reprod Med. 2015 Jul-Aug;60(7-8):354-8
pubmed: 26380496
Nat Rev Endocrinol. 2013 Dec;9(12):735-49
pubmed: 24166000
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1304-12
pubmed: 19306747
J Reprod Med. 2015 Jul-Aug;60(7-8):345-53
pubmed: 26380495
Obstet Gynecol Surv. 2008 Nov;63(11):725-32
pubmed: 18928577
Eur J Surg Oncol. 1990 Apr;16(2):141-6
pubmed: 2323410
Reprod Biomed Online. 2009 Aug;19(2):250-1
pubmed: 19712562
Curr Oncol. 2015 Aug;22(4):e294-304
pubmed: 26300680
Acta Inform Med. 2013;21(2):135-7
pubmed: 24058255
Hum Reprod Update. 2004 May-Jun;10(3):251-66
pubmed: 15140872
Arch Gynecol Obstet. 2011 Aug;284(2):427-35
pubmed: 21431846
Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):465-469
pubmed: 27685935
Eur J Gynaecol Oncol. 2007;28(5):408-10
pubmed: 17966224
Fertil Steril. 1998 Nov;70(5):956-60
pubmed: 9806584
Fertil Steril. 2005 May;83(5):1547-9
pubmed: 15866599
Int J Gynecol Cancer. 1994 Jan;4(1):61-65
pubmed: 11578386
Int J Radiat Oncol Biol Phys. 1993 Feb 15;25(3):419-24
pubmed: 8436519
Gynecol Oncol. 1987 Nov;28(3):255-61
pubmed: 3678976
Am J Obstet Gynecol. 1958 Mar;75(3):590-600; discussion 600-5
pubmed: 13508748